Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M702159200 on July 2, 2007

J. Biol. Chem., Vol. 282, Issue 34, 24689-24696, August 24, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/34/24689    most recent
M702159200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, E. G.
Right arrow Articles by Woodgate, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, E. G.
Right arrow Articles by Woodgate, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increased Catalytic Activity and Altered Fidelity of Human DNA Polymerase {iota} in the Presence of Manganese*

Ekaterina G. Frank and Roger Woodgate1

From the Laboratory of Genomic Integrity, NICHD, National Institutes of Health, Bethesda, Maryland 20892-2725

Received for publication, March 13, 2007 , and in revised form, July 2, 2007.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
All DNA polymerases require a divalent cation for catalytic activity. It is generally assumed that Mg2+ is the physiological cofactor for replicative DNA polymerases in vivo. However, recent studies suggest that certain repair polymerases, such as pol {lambda}, may preferentially utilize Mn2+ in vitro. Here we report on the effects of Mn2+ and Mg2+ on the enzymatic properties of human DNA polymerase {iota} (pol {iota}). pol {iota} exhibited the greatest activity in the presence of low levels of Mn2+ (0.05–0.25 mM). Peak activity in the presence of Mg2+ was observed in the range of 0.1–0.5 mM and was significantly reduced at concentrations >2 mM. Steady-state kinetic analyses revealed that Mn2+ increases the catalytic activity of pol {iota} by ~30–60,000-fold through a dramatic decrease in the Km value for nucleotide incorporation. Interestingly, whereas pol {iota} preferentially misinserts G opposite T by a factor of ~1.4–2.5-fold over the correct base A in the presence of 0.25 and 5 mM Mg2+, respectively, the correct insertion of A is actually favored 2-fold over the misincorporation of G in the presence of 0.075 mM Mn2+. Low levels of Mn2+ also dramatically increased the ability of pol {iota} to traverse a variety of DNA lesions in vitro. Titration experiments revealed a strong preference of pol {iota} for Mn2+ even when Mg2+ is present in a >10-fold excess. Our observations therefore raise the intriguing possibility that the cation utilized by pol {iota} in vivo may actually be Mn2+ rather than Mg2+, as tacitly assumed.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
It has been known for several decades that DNA polymerases (pol)2 require a divalent cation as an activator for phosphotidyl transfer (13). Two metal ions are usually coordinated by three acidic amino acids within the active site of the polymerase, so as to form a metal bridge between the enzyme and the terminal phosphoryl group of the substrate (4, 5), thereby facilitating the departure of the pyrophosphate moiety (6). Based upon its cellular abundance, it is generally believed that Mg2+ is the activating cofactor in vivo. However, Mn2+, Co2+, Ni2+, and Zn2+ have the capacity to substitute for Mg2+ under certain conditions in vitro (2, 3, 7), but usually at the consequence of reduced fidelity and in some cases decreased processivity. The effect of substituting Mg2+ with Mn2+ on the activity of A- and B-family polymerases has been widely studied (812). In addition to reducing fidelity, Mn2+ also helps facilitate translesion synthesis by certain replicative polymerases, including Escherichia coli pol I (13) and herpes simplex virus-1 UL30 protein (14) but not others, such as T4 DNA polymerase, or bovine pol {delta} (12, 14).

The effect of Mn2+ on X-family polymerases has also been studied. In the case of pol beta, Mn2+ decreases the Km value of nucleotide incorporation by ~30-fold (15), such that there is little regard for the instructions provided by the templating base (16). Recent data also suggest that the phylogenetically related pol {lambda} may have actually evolved to utilize Mn2+ under physiological conditions, because the enzyme is active over a wide range of Mn2+ concentrations and is inhibited by high levels of Mg2+ (17, 18).

To date, there have been few studies on the effects of Mn2+ on the Y-family of DNA polymerases. In the single published report, Sulfolobus solfataricus Dpo4 behaved in a similar manner to the replicative polymerases, in that 5 mM Mn2+ increased the efficiency of lesion bypass, but with a concomitant 3–4-fold decrease in the overall fidelity of the enzyme (19). The effect of Mn2+ on other Y-family polymerases, including human DNA polymerases {eta}, {iota}, and {kappa}, is largely unknown. We were therefore very interested in determining the effects of various metal ions on the activity of the human Y-family polymerases and in particular pol {iota}, because its reported biochemical properties are quite unusual. Indeed, pol {iota} exhibits a remarkable template-dependent fidelity in vitro. When replicating template T in the presence of Mg2+, pol {iota} preferentially misinserts G over the correct base A by a factor of 3–10-fold (2024). In contrast, when replicating template A, the enzyme is relatively accurate with misincorporations occurring in the range of 10–3–10–4 (2022). Thus, the fidelity of pol {iota} can vary by up to 100,000-fold depending upon the template sequence being replicated. Here we report on the enzymatic properties of pol {iota} in vitro in the presence of various divalent cations, in particular Mg2+ and Mn2+.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Enzymes—N-terminal glutathione S-transferase-tagged human pol {iota} was expressed and purified from baculovirus-infected insect Sf9 cells as described (20). C-terminal His-tagged human pol {eta} (25) was also expressed in baculovirus-infected Sf21 cells and purified by nickel-agarose, Q-Sepharose, and Bio-Gel HT hydroxyapatite chromatography. N-terminal His-tagged human pol {kappa} (26) was purchased from Enzymax (Lexington, KY).

Primers and Templates—All primers, undamaged templates, and the abasic site-containing template, TXT30, were synthesized by Lofstrand Laboratories (Gaithersburg, MD) and gelpurified prior to use. The cyclobutane pyrimidine dimer containing template, TTA48, was synthesized and purified by Phoenix Biotechnologies, Inc. (Huntsville, AL). The pyrimidine-pyrimidone (6-4)-containing template, 6-4TT30, was a kind gift from Shigenori Iwai (Osaka University). The benzo-[a]pyrene diol epoxide-containing template, BPDE29, was a kind gift from Don Jerina (NIDDK, National Institutes of Health). For the experiments presented in Fig. 1, the template was T50, 5'-CGT CTA GAC GAA TTC ACG GCT CAA GCT TGC TTG CGC ATG CTC TGC AGG CG-3', and the primer was a 22-mer that was complementary to the template nucleotides underlined. The template used for the experiments presented in Figs. 2 and 5 and Table 1, parts B and C, was T50M13, 5'-CGG TAA TGA TTC CTA CGA TGA AAA TAA AAA CGG CTT GCT TGT TCT CGA TG-3', which corresponds to M13mp18 (nucleotides 3486–3437) (27). The primer was a 20-mer complementary to the template nucleotides underlined. The experiments described in Fig. 3 and Table 1, Part A utilized 48-mer templates UTTA and TTA48, with the sequence 5'-TCG ATA CTG GTA CTA ATG ATT AAC GAA TTA AGC ACG TCC GTA CCA TCG-3'. The primer was a 16-mer that was complementary to the template nucleotides underlined. The adjacent Ts were covalently linked to form a cyclobutane pyrimidine dimer (CPD) in template TTA48. The experiments described in Fig. 4 utilized three lesion-containing templates. TXT30 was a 30-mer with the sequence 5'-CTC GTC AGC ATC TXC ATC ATA CAG TCA GTG-3', where the X was a synthetic tetrahydrofuran moiety (abasic site). The primer was a 16-mer that was complementary to the template nucleotides underlined. The second template, BPDE29, was a 29-mer with the sequence 5'-GCT CGT CAG CAG ATT TAG AGT CTG CAG TG-3', where the A has a benzo[a]pyrene adduct at its N6 position (28). The primer was a 16-mer that was complementary to the template nucleotides underlined. The third template, 6-4TT30, was a 30-mer with the sequence 5'-CTC GTC AGC ATC TTC ATC ATA CAG TCA GTG-3', where the two Ts indicate a 6-4 pyrimidine-pyrimidone dimer (29). The primer was a 16-mer that was complementary to the template nucleotides underlined. All primers were 5'-labeled with [{gamma}-32P]ATP (5000 Ci/mmol; 1 Ci = 37 gBq) (GE Healthcare).


View this table:
[in this window]
[in a new window]

 
TABLE 1
Kinetics of pol {iota} (mis)insertion in the presence of Mg2+ and Mn2+

 
Annealing Primers to Templates—100 nM of 32P-labeled primer was mixed with 150 nM of the corresponding template in 50 mM Tris·HCl (pH 8.0), 10 mM NaCl, 1.42 mM 2-mercaptoethanol, and 50 µg/ml bovine serum albumin, heated at 95 °C for 5 min, and then slowly cooled to room temperature over a period of several hours.

Primer Extension Reaction—Standard replication reactions (10 µl) contained 40 mM Tris·HCl (pH 8.0), 2.5% glycerol, 0.1 mg/ml bovine serum albumin, 10 mM dithiothreitol, 10 nM of 5'-32P-labeled primer-template DNA, 2 nM glutathione S-transferase-pol {iota}, 5 nM His-pol {eta}, or His-pol {kappa}. Reaction times, divalent metal ions, in the form of –Cl2 salt, and dNTPs concentrations are specified in the figures and legends. After incubation at 37 °C, reactions were terminated by addition of 10 µl of 95% formamide, 10 mM EDTA, and samples were heated to 100 °C for 5 min and then immediately transferred on ice. The reaction products were separated by 15% polyacrylamide, 8 M urea gel electrophoresis and analyzed using a Fuji FLA-5100 PhosphorImager and ImageGauge software.


Figure 1
View larger version (62K):
[in this window]
[in a new window]

 
FIGURE 1.
Catalytic activity of human DNA polymerases {iota}, {eta}, and {kappa} in the presence of various divalent cations. The ability of pol {iota} (A), pol {eta} (B), or pol {kappa} (C) to extend a 32P-labeled 22-mer primer annealed to template "T50" was assayed in the presence of 50 µM of all four dNTPs and 0.5 or 5 mM divalent metal ions (as the chloride salt), for 30 min at 37 °C.

 
Steady-state Kinetics—Steady-state kinetic parameters Vmax and Km, for incorporation opposite template T or A, were measured in standing-start reactions as described previously (20, 27, 28). Reactions contained 0.4 nM of pol {iota}, and conditions were optimized to ensure that the reaction remains in a linear range. For reactions measuring incorporation opposite template A in the presence of 0.075 mM Mn2+, we used 0.0001–0.0015 µM of dTTP and 0.0005–0.003 µM of dATP in 3-min reactions. For reactions containing 0.25 mM Mg 2+, we varied the concentration of dTTP from 0.001 to 0.015 µM and dATP from 10 to 100 µM in 2-min reactions. For reactions containing 5 mM Mg 2+, we varied the concentration of dTTP from 0.005 to 0.03 µM and dATP from 10 to 100 µM in 2.5-min reactions. In reactions where both metal ions were present (0.075 mM Mn2+/0.25 mM Mg2+), we used 0.001–0.02 µM of dTTP and 0.025–0.15 µM of dATP in 2-min reactions. To measure incorporation opposite template T, in the presence of 0.075 mM Mn2+, we varied dNTPs concentrations from 0.0001 to 0.0015 µM in 2.5-min reactions. Reactions in the presence of 0.25 mM Mg2+ contained dNTPs that ranged in concentration from 0.005 to 0.03 mM in 2.5-min reactions, whereas in assays containing 5 mM Mg2+, the dNTPs ranged from 20 to 150 µM in 2-min reactions. Reaction mixtures were subjected to 15% polyacrylamide, 8 M urea gel electrophoresis and analyzed using Fuji FLA-5100 PhosphorImager and ImageGauge software. Saturation plots of velocity as a function of dNTPs concentrations (in µM) were calculated as a percentage of the primer extension per min. Vmax and Km values were determined from a Hanes-Woolf plot by linear least squares fit as described (27) using Sigma Plot software (SPSS, Chicago).


Figure 2
View larger version (75K):
[in this window]
[in a new window]

 
FIGURE 2.
Determination of the optimal concentration of Mn2+ or Mg2+ required for maximal activity of human pol {iota} and pol {eta} in vitro. The ability of pol {iota} (top) and pol {eta} (bottom) to extend a 32P-labeled 20-mer primer annealed to template "T50M13" was assayed in the presence of 50 µM of all four dNTPs and various concentrations of MnCl2 or MgCl2 ranging from 0.05 to 8 mM in 20-min reactions at 37 °C. The sequence of the template immediately downstream of the primer (Pr.) is shown on the left-hand side of each gel. The arrows indicate the location of a template T that is located 6 bp from the end of the primer terminus. In the presence of Mg2+, pol {iota} frequently misincorporates G opposite template T. The mispair is poorly extended compared with the correct base pair, and as a consequence a strong pause site is observed 6 bp from the primer terminus. Thus, one measurement of the overall catalytic activity of pol {iota} is its ability to extend beyond the normal pause site at template T. When products 7 bp and longer are plotted as a function of Mn2+ ({blacktriangleup}) or Mg2+ ({triangleup}), it is clear that pol {iota} exhibits greatest activity at 0.075 mM Mn2+ and 0.25–0.5 mM Mg2+. Although pol {eta} does not pause at template T, we used the same method to determine the optimal conditions for pol {eta} activity. As can be seen (lower panels), pol {eta} exhibits greatest activity in 0.05–0.1 mM Mn2+ and 0.1–2 mM Mg2+.

 

    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Effects of Various Divalent Metal Ions on the Activity of Human Y-family Polymerases—The ability of human DNA polymerases {iota}, {eta}, and {kappa} to utilize various divalent cations as activators for polymerization was assayed in replication reactions using a radiolabeled 22-mer primer annealed to a 50-mer oligonucleotide template. Each metal ion was present as the chloride salt, at a concentration of either 0.5 or 5 mM. Quite surprisingly, of the eight divalent cations assayed, only Cu2+ failed to support any catalysis. The remaining seven cations all promoted polymerization to some extent, with the degree of activation being acutely polymerase-specific (Fig. 1). As expected, robust synthesis was observed with pol {eta} and pol {kappa} in the presence of both 0.5 and 5 mM Mg2+. In contrast, however, the activity of pol {iota} was far greater in 0.5 mM Mg2+ than in 5 mM Mg2+ (Fig. 1). All three polymerases were highly active in the presence of Mn2+ with greater activity observed in 0.5 mM Mn2+ compared with 5 mM Mn2+. Co2+ also served as an activator for all three polymerases, with pol {eta} being the most active of the three enzymes in 0.5 mM Co2+. Similarly, pol {eta} was more active than either pol {iota} or pol {kappa} in the presence of Ca2+ or Zn2+. In contrast, pol {kappa} exhibited much greater activity in the presence of 5 mM Cd2+ or Ni2+, compared with either pol {iota} or pol {eta}. We conclude from these studies that each human Y-family polymerase possesses its own unique ability to utilize different metals as cofactors for DNA synthesis. In the case of pol {eta} and pol {kappa}, the preferred activator appears to be Mg2+. However, based upon the data presented in Fig. 1, pol {iota} either prefers low levels of Mg2+ or Mn2+ for optimal activity in vitro.

Titration of Mn2+ or Mg2+ in pol {iota} and pol {eta} Replication Reactions—We next determined the optimum concentration of Mg2+ or Mn2+ required to promote peak activity of pol {iota} or pol {eta} by performing primer extension assays in the presence of Mg2+ or Mn2+ ranging in concentrations from 0.05 to 8 mM. The template for these assays was a 50-mer oligonucleotide that has a run of five template As followed by a T and then four additional As immediately downstream of the primer. This sequence context was chosen, as we have previously shown that in the presence of 5 mM Mg2+ pol {iota} readily incorporates T opposite the five template As, but then frequently misinserts G opposite template T (29). The efficiency of G (or A) insertion opposite T is much lower than that of the incorporation of T opposite A (20). Further elongation from the mispair is also reduced compared with that of the correct A:T base pair (24), and as a consequence, there is a strong pol {iota}-dependent pause 5–6 bases from the starting primer terminus (Fig. 2, top, 0.1–0.5 mM Mg2+). The percentage of replication products longer than 6 bp therefore provides a reasonably accurate method of measuring the catalytic activity of pol {iota}. By using this approach, it is readily obvious that pol {iota} is very active in the presence of low levels of Mn2+ (Fig. 2, top, left-hand panel). Presumably, the ability of pol {iota} to overcome the kinetic block to replication when the enzyme encounters a template T reflects a change in the specificity of nucleotide (mis)insertion (see below for more detailed analysis), as well as through an increased ability to extend G:T mispairs.3 The peak activity of pol {iota} was observed in the range of 0.05–0.2 mM Mn2+. Similarly, pol {iota} was also much more active in the presence of low levels of Mg2+, with peak activity occurring within the range of 0.2–0.5 mM Mg2+. Indeed, higher concentrations of Mg2+ appear to inhibit pol {iota}, as under these assay conditions the limiting amount of pol {iota} in the reaction was barely sufficient to elongate the primer by 1–2 bp (Fig. 2, right-hand panel, 8 mM Mg2+).


Figure 3
View larger version (82K):
[in this window]
[in a new window]

 
FIGURE 3.
pol {iota}- and pol {eta}-dependent bypass of a T-T CPD in the presence of Mn2+ or Mg2+. The ability of pol {iota} (A)orpol {eta} (B) to extend a 32P-labeled 20-mer primer (Pr.) annealed to the CPD-containing "TTA48" template was assayed in the presence of 100 µM of all four dNTPs and various concentrations of MnCl2 or MgCl2 ranging from 0.05 to 8 mM in 30-min reactions at 37 °C. The location of the T-T CPD in the TTA48 template is indicated (>TT). A graph depicting the percent of lesion bypass (products extended beyond the T-T) in the presence of various concentrations of Mn2+ ({blacktriangleup}) or Mg2+ ({triangleup}) is shown on the right-hand side of each panel.

 
In parallel experiments with human pol {eta}, the enzyme was very active in the presence of 0.05–0.1 mM Mn2+, but it rapidly began to lose activity at higher concentrations and was severely inhibited in reactions containing >2 mM Mn2+. Peak activity of pol {eta} in the presence of Mg2+ was observed in the range of 0.075–2 mM Mg2+, and similar to pol {iota}, the limiting amount of pol {eta} in the reaction appeared to have somewhat reduced activity in 5–8 mM Mg2+.

In an attempt to further optimize the in vitro reaction conditions for pol {iota} synthesis, we also performed replication assays in the presence of low Mn2+ or Mg2+ in buffers that ranged in pH from 7.5 to 9.0 and in the presence of increasing amounts of NaCl. In general, changing the pH of the assay buffer had little effect on the activity of the enzyme. In contrast, the activity of pol {iota} steadily decreased as the concentration of NaCl was increased from 0 to 150 mM.3

Activity of pol {iota} and pol {eta} on a CPD-containing Template in the Presence of Mg2+ and Mn2+—We have previously reported that in the presence of 5 mM Mg2+, pol {iota} is capable of inserting a base opposite the 3'T of a T-T CPD, as well as facilitating low levels of complete translesion synthesis (30, 31). We therefore wanted to reinvestigate the ability of pol {iota} to facilitate translesion synthesis over a range of Mg2+ and Mn2+ concentrations (Fig. 3). In these reactions, the 3' end of the primer was juxtaposed to the CPD and are therefore considered "standing start" reactions. Similar to the observations reported above, maximal activity for pol {iota} was observed in the range of 0.075–0.25 mM Mn2+ on the damaged template (Fig. 3A). Under these conditions, there was significant extension of primers past the CPD. Indeed, we estimate that approximately 60% of the primer was elongated past the CPD by pol {iota} in the presence of 0.2 mM Mn2+ (Fig. 3A, right-hand panel). The results with Mg2+ were similar to our earlier published observations (30, 31), in that the 3'T of the CPD is a strong kinetic block to pol {iota} and elongation past the 3'T was greatest in the range of 0.25–2 mM Mg2+. Indeed, we estimate that in the presence of 0.5 mM Mg2+, ~8% of the primers are elongated past both Ts of the CPD, compared with ~2.5% in the presence of 5 mM Mg2+, which is consistent with our earlier observations (30, 31).

The ability of pol {eta} to bypass a CPD in vitro is unrivalled. It does so with the same or even higher efficiency than it replicates undamaged DNA (3234). In the presence of Mn2+, robust bypass activity was observed from 0.05 to 0.25 mM Mn2+, but bypass activity steadily declined as the Mn2+ concentration increased (Fig. 3B). In contrast, pol {eta} exhibited strong bypass activity in the presence of 0.05–8 mM Mg2+.

We conclude from these studies that pol {iota} and pol {eta} have differing affinities for metal ion activation. Translesion synthesis of a CPD by pol {iota} is stimulated ~3-fold by low levels of Mg2+ and up to 25-fold in the presence of 0.2 mM Mn2+ compared with 5 mM Mg2+. In contrast, pol {eta} appears to exhibit efficient bypass a CPD over a wide range of Mg2+ concentrations.


Figure 4
View larger version (73K):
[in this window]
[in a new window]

 
FIGURE 4.
pol {iota}-dependent bypass of an abasic site, BPDE lesion, and 6-4PP lesion in the presence of Mn2+ or Mg2+. The ability of pol {iota} to extend 32P-labeled primers (Pr.->) annealed to the abasic-containing template, TXT30 (A), the BPDE-containing template, BPDE29 (B), or the 6-4PP containing template, 6-4TT30 (C), was assayed in the presence of 100 µM of all four dNTPs and various concentrations of MnCl2 or MgCl2 ranging from 0.05 to 8 mM in 30-min reactions at 37 °C. The location of the abasic site is indicated by <-AP, the BPDE lesion by <-BP, and the 6-4PP indicated by >6-4.A graph depicting the percent of lesion bypass (products extended beyond the abasic site, the BPDE lesion, or the 6-4T-T), in the presence of various concentrations of Mn2+ ({blacktriangleup}) or Mg2+ ({triangleup}), is shown on the right-hand side of each panel.

 
General Ability of Mn2+ to Stimulate Translesion Synthesis by pol {iota}—We next examined whether low levels of Mn2+ or Mg2+ would stimulate pol {iota}-dependent synthesis of a synthetic abasic site, a BPDE adduct, and a 6-4PP lesion (Fig. 4). Previous in vitro studies in the presence of 5 mM Mg2+ indicated that pol {iota} can efficiently incorporate a nucleotide opposite an abasic site, a benzo[a]pyrene lesion, and up to two bases opposite the 6-4PP; however, further extension is limited (21, 30, 35). The previous results are recapitulated here in the presence of 5–8 mM Mg2+ (Fig. 4). Lower concentrations of Mg2+ helped stimulate incorporation opposite each of the three lesions but had little effect on bypass of the lesion. In contrast, in the presence of 0.2 mM Mn2+, pol {iota}-dependent bypass of the abasic site increased to ~18%, and bypass of the BPDE adduct increased to ~10% (Fig. 4, A and B). However, whereas Mn2+ appears to stimulate the ability of pol {iota} to incorporate opposite both bases of the 6-4PP, it did not appreciably alter the extent of 6-4PP lesion bypass.

pol {iota} Has Higher Affinity for Mn2+ than Mg2+—As noted earlier, in the presence of Mg2+ pol {iota} readily misinserts G opposite template T, causing the enzyme to pause. This pausing is much less evident in the presence of Mn2+, with the accumulation of a significant proportion of replication products longer than 6 bp (Fig. 2, top). These two distinguishable properties gave us an opportunity to assay which cation pol {iota} prefers to utilize when presented with both Mn2+ and Mg2+. In the experiments depicted in Fig. 5, pol {iota} was first preincubated in the presence of various concentrations of Mn2+ (Fig. 5A), or Mg2+ (Fig. 5B), for 5 min at room temperature. Reactions were started by the addition of various concentrations of either Mg2+ or Mn2+ and the radio-labeled primer/template, followed by incubation at 37 °C for 20 min. As shown in Fig. 5, it is clear that when preincubated with Mn2+ and then challenged with Mg2+, the pol {iota}-dependent replication products are reminiscent of those observed in the presence of Mn2+ alone, with very little pausing at template T (Fig. 5A). This property occurs over a wide range of Mn2+/Mg2+ concentrations, and is even evident when Mg2+ is present in a 40-fold molar excess over Mn2+ (see Fig. 5A, 0.05 mM Mn2+/2 mM Mg2+).

The preference of pol {iota} for Mn2+ is more evident in the reactions in which pol {iota} was preincubated in the presence of Mg2+ and then challenged with Mn2+ (Fig. 5B). In the absence of added Mn2+, the Mg2+ reactions exhibited the classic termination pattern, with a strong pause 5–6 bp downstream of the primer. However, in all reactions containing Mn2+ this pausing is significantly reduced. Again, Mn2+ stimulation occurred over a wide range of Mg2+/Mn2+ concentrations and was obvious even when Mg2+ was present in a 10–40-fold molar excess over Mn2+. Based upon these observations, we conclude that pol {iota} preferentially utilizes Mn2+ as the activator for polymerization, even in reactions containing a vast molar excess of Mg2+.

Kinetics of pol {iota}-dependent Incorporation in the Presence of Mn2+ and/or Mg2+—Several groups have previously reported the kinetic parameters for pol {iota}-dependent nucleotide incorporation on an undamaged template. In all cases, these values were determined in the presence of 5 or 8 mM Mg2+ (2022). Under these conditions, the two most striking properties of pol {iota} are its ability to preferentially misinsert G opposite T and to faithfully and efficiently incorporate A opposite T. However, our present studies indicate that pol {iota} is much more catalytically active at much lower concentrations of Mg2+ and Mn2+. We have therefore determined the kinetic parameters for (mis)insertion opposite template T and A, in the presence of 0.075 mM Mn2+, 0.25 mM Mg2+, and 5 mM Mg2+ either alone (Table 1, parts A and B), or in combination (Table 1, part C). These kinetic studies revealed that the increase in catalytic activity observed in our earlier experiments is largely derived from a dramatic decrease in the Km value for nucleotide incorporation. Indeed, whereas the Vmax was essentially unchanged under all assay conditions, the Km value varied by as much as 2400-fold at template T and 30,000-fold at template A. For example, the Km value for the correct incorporation of A opposite T decreased by ~245-fold in the presence of 0.25 mM Mg2+ compared with 5 mM Mg2+, and there was a further 10-fold reduction in the presence of 0.075 mM Mn2+. The Km value for the misincorporation of G opposite T also dropped dramatically but to a slightly lower extent. As a result, there was an overall change in the frequency of misincorporation (finc) under the various assay conditions. Although misincorporation of G opposite T was favored by a factor of 2.5-fold in 5 mM Mg2+ and by 1.4-fold in 0.25 mM Mg2+, in reactions containing 0.075 mM Mn2+, the correct incorporation of A was actually favored ~2.3-fold more than G. Thus, in contrast to its fidelity-reducing effects on all known polymerases, Mn2+ actually increases the fidelity of pol {iota} at template T. It should be stressed, however, that even though Mn2+ altered the relative ratios of (mis)incorporation opposite template T so as to favor the incorporation of the correct base, pol {iota} nevertheless remains extremely error-prone under these conditions.


Figure 5
View larger version (101K):
[in this window]
[in a new window]

 
FIGURE 5.
Activation of pol {iota} catalysis in the presence of Mn2+ and Mg2+. The ability of pol {iota} to extend a 32P-labeled 20-mer primer annealed to template "T50M13" was assayed in the presence of 50 µM all four dNTPs and various concentrations of MnCl2 and MgCl2. In the experiments shown in A, pol {iota} was preincubated in the presence of Mn2+ for 5 min and reactions were started by the addition of various concentrations of Mg2+ together with the annealed primer template. Reactions were terminated after 20 min at 37 °C. In the experiments shown in B, pol {iota} was preincubated in the presence of Mg2+ for 5 min and reactions were started by the addition of various concentrations of Mn2+ together with the annealed primer template and were terminated after 20 min at 37 °C. The sequence of the template immediately downstream of the primer (Pr.) is shown on the left hand side of each panel. The arrows indicate the location of a template T that represents a strong pause site for pol {iota} in the presence of Mg2+ alone. As can be clearly seen, pausing at this site is diminished in reactions containing Mn2+.

 
At template A, 0.075 mM Mn2+ caused the characteristic decrease in fidelity as there was a dramatic increase in the frequency of misincorporation of A, over the correct base T (Table 1, part B). Similar to our observations above, these effects were largely driven by changes in the Km value for nucleotide incorporation. The largest effect was on the Km value for misinsertion of A, where it dropped from 70 to 90 µM in the presence of Mg2+ to 0.003 µM for Mn2+ (~23,000–30,000-fold difference).

Overall, the catalytic activity (Vmax/Km)ofpol {iota} increased in the presence of low levels of Mg2+ or Mn2+. The smallest effect was observed for (mis)incorporation opposite A, where the catalytic activity only increased ~2–2.5-fold in the presence of 0.25 mM Mg2+ compared with 5 mM Mg2+. However, much larger effects were observed at template T, where the catalytic activity increased ~45–80-fold in 0.25 mM Mg2+ compared with 5 mM Mg2+. The effects of 0.075 mM Mn2+ were much more dramatic, with an additional ~11–3300-fold increase in catalytic activity over that observed in the presence of 0.25 mM Mg2+.

In the simultaneous presence of 0.075 mM Mn2+ and 0.25 mM Mg2+, the catalytic activity (Vmax/Km)ofpol {iota} for the correct incorporation of T opposite A was intermediate to that observed in the presence of each individual cation. For example, the catalytic activity of pol {iota} was ~4.5-fold lower than in the presence of 0.075 mM Mn2+ alone but ~2.6-fold higher than in the presence of 0.25 mM Mg2+ alone. With regard to fidelity, Mn2+ appears to be dominant, in that pol {iota} exhibited ~200-fold lower fidelity in the presence of both Mn2+ and Mg2+ compared with that observed in the presence of 0.25 mM Mg2+ alone.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study, we have investigated the effects of various divalent cations on the in vitro properties of human DNA polymerases {eta}, {iota}, and {kappa}. The most abundant divalent cation is Mg2+, with an intracellular concentration of 0.21 to 0.24 mM (36, 37). Given its abundance, Mg2+ is therefore generally considered to be the physiologically relevant divalent metal cofactor for most DNA polymerases. In support of this notion, our analyses strongly suggest that the preferred cation for pol {eta} and pol {kappa} is Mg2+, as both enzymes were active over a wide range of Mg2+ concentrations. In contrast, pol {iota} exhibited greatest activity within a much more narrow concentration range of Mg2+ (Fig. 2). Peak activity was observed at 0.25 mM Mg2+, and synthesis was reduced significantly in reactions containing >2 mM Mg2+. As far as we are aware, all of the published reports on the biochemical properties of pol {iota} in vitro were performed in the presence of 5 or 8 mM Mg2+ and were therefore performed under suboptimal conditions (2024, 28, 30, 31, 35, 3842). Indeed, it appears that in the presence of low levels of Mg2+, pol {iota} may exhibit higher catalytic activity and fidelity than previously thought (Table 1).

Limited synthesis by pol {eta}, pol {iota}, and pol {kappa} was observed in the presence of many different divalent cations, but in most cases, the concentration required for replication occurred well outside the physiological concentration of the trace metal, and is therefore probably of little biological significance. The exception was the ability of pol {iota} to utilize low levels of Mn2+ as an activator for catalysis (Fig. 2). The cellular concentration of Mn2+ in mammalian cells is much lower than that of Mg2+ and is thought to be in the range of 0.1 to 40 µM (4345). Our current studies indicate that in vitro, the optimum concentration of Mn2+ required for maximal stimulation of pol {iota} on an undamaged template occurs around 0.075 mM (75 µM). Although this concentration may lie outside the physiological range of Mn2+ available to most cells, pol {iota} nevertheless exhibited a strong preference for Mn2+ over Mg2+, even when Mg2+ was in a 10–20-fold excess. Our steady-state kinetic analyses revealed that Mn2+ stimulated the catalytic activity of pol {iota} through a dramatic decrease in the Km value for nucleotide incorporation. Interestingly, when both Mn2+ and Mg2+ were present at optimal concentrations (0.075 and 0.25 mM, respectively), pol {iota} exhibited kinetic parameters that more closely resembled those observed in the presence of Mn2+ alone (Table 1, part C), which infers that Mn2+ is the preferred activator for polymerization.

The structural basis for the enhanced catalytic activity of pol {iota} in the presence of Mn2+ is presently unknown. However, it is clear that Mn2+ has a more relaxed coordination than Mg2+, thereby facilitating reactions that are suboptimal or even inhibited in the presence of Mg2+ (5). Indeed, the crystal structure of pol {iota} reveals that its active site is somewhat distorted and has large side chains protruding into the space normally occupied by the replicating base pair (40). Mn2+ may therefore simply allow greater flexibility of the active site of pol {iota}, such that it can adopt a conformation that is more favorable for catalysis.

The effects of Mn2+ on the fidelity of pol {iota} were unique. Although it caused a characteristic reduction in fidelity at template A, Mn2+ actually increased fidelity at template T, by 3–5-fold compared with the fidelity of pol {iota} in the presence of 0.25 or 5 mM Mg2+, respectively. Low levels of Mg2+ and Mn2+ also had dramatic effects on the ability of pol {iota} to traverse a T-T CPD. The efficiency of bypass increased from ~2.5% in the presence of 5 mM Mg2+ to ~8% in the presence of 0.5 mM Mg2+ and up to ~60% in the presence of 0.2 mM Mn2+. Thus, under certain conditions in vitro pol {iota} can bypass a T-T CPD relatively efficiently. Presumably conditions favorable for the pol {iota}-dependent bypass of CPDs also occur in vivo. Such an assumption is supported by the recent reports that implicate cellular roles for pol {iota} in UV-induced mutagenesis and carcinogenesis in mice and humans (4648). The stimulatory effect of Mn2+ on pol {iota}-dependent lesion bypass was not limited to the T-T CPD, as bypass of an abasic site increased from ~1 to 2% in the presence of Mg2+ to ~18% in the presence of Mn2+. Similarly, bypass of a BPDE lesion also increased from ~2.5 to ~10% in the presence of Mg2+ and Mn2+, respectively, thereby raising the possibility that pol {iota} may also bypass these lesions in vivo.

In summary, pol {iota} is more active in the presence of physiological concentrations of Mg2+ than at concentrations previously used in vitro to study the enzymatic properties of the polymerase. We therefore suggest that future in vitro studies on pol {iota} be conducted in buffers containing low Mg2+ (0.25–2 mM). We also discovered that the enzyme is highly active in low concentrations of Mn2+. When asked to select between Mg2+ and Mn2+, pol {iota} clearly prefers to utilize Mn2+, even when Mg2+ is in large molar excess. Whether a similar situation occurs in vivo remains to be determined, but it nevertheless remains an intriguing possibility certainly worth considering.


    FOOTNOTES
 
* This work was funded by the Intramural Research Programs of the NICHD, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Bldg. 6, Rm. 1A13, NICHD, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-2725. Tel.: 301-496-6175; Fax: 301-594-1135; E-mail: woodgate{at}nih.gov.

2 The abbreviations used are: pol, DNA polymerase; CPD, cyclobutane pyrimidine dimer; 6-4PP, pyrimidine-pyrimidone (6-4); BPDE, Benzo[a]pyrene diol epoxide. Back

3 E. G. Frank and R. Woodgate, unpublished observations. Back


    ACKNOWLEDGMENTS
 
We thank Wei Yang for insights and comments on the possible structural basis for Mn2+ stimulation of the catalytic activity of pol {iota}.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bessman, M. J., Lehman, I. R., Simms, E. S., and Kornberg, A. (1958) J. Biol. Chem. 233, 171–177[Free Full Text]
  2. Mildvan, A. S., and Loeb, L. A. (1979) CRC Crit. Rev. Biochem. 6, 219–244[Medline] [Order article via Infotrieve]
  3. Loeb, L. A., and Kunkel, T. A. (1982) Annu. Rev. Biochem. 51, 429–457[CrossRef][Medline] [Order article via Infotrieve]
  4. Steitz, T. A. (1999) J. Biol. Chem. 274, 17395–17398[Free Full Text]
  5. Yang, W., Lee, J. Y., and Nowotny, M. (2006) Mol. Cell 22, 5–13[CrossRef][Medline] [Order article via Infotrieve]
  6. Sloan, D. L., Loeb, L. A., and Mildvan, A. S. (1975) J. Biol. Chem. 250, 8913–8920[Abstract/Free Full Text]
  7. Sirover, M. A., and Loeb, L. A. (1976) Biochem. Biophys. Res. Commun. 70, 812–817[CrossRef][Medline] [Order article via Infotrieve]
  8. Goodman, M. F., Keener, S., Guidotti, S., and Branscomb, E. W. (1983) J. Biol. Chem. 258, 3469–3475[Abstract/Free Full Text]
  9. El-Deiry, W. S., Downey, K. M., and So, A. G. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 7378–7382[Abstract/Free Full Text]
  10. Beckman, R. A., Mildvan, A. S., and Loeb, L. A. (1985) Biochemistry 24, 5810–5817[CrossRef][Medline] [Order article via Infotrieve]
  11. Zakharova, E., Wang, J., and Konigsberg, W. (2004) Biochemistry 43, 6587–6595[CrossRef][Medline] [Order article via Infotrieve]
  12. Hays, H., and Berdis, A. J. (2002) Biochemistry 41, 4771–4778[CrossRef][Medline] [Order article via Infotrieve]
  13. Rabkin, S. D., Moore, P. D., and Strauss, B. S. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 1541–1545[Abstract/Free Full Text]
  14. Villani, G., Tanguy Le Gac, N., Wasungu, L., Burnouf, D., Fuchs, R. P., and Boehmer, P. E. (2002) Nucleic Acids Res. 30, 3323–3332[Abstract/Free Full Text]
  15. Wang, T. S., Eichler, D. C., and Korn, D. (1977) Biochemistry 16, 4927–4934[CrossRef][Medline] [Order article via Infotrieve]
  16. Pelletier, H., Sawaya, M. R., Wolfle, W., Wilson, S. H., and Kraut, J. (1996) Biochemistry 35, 12762–12777[CrossRef][Medline] [Order article via Infotrieve]
  17. Blanca, G., Shevelev, I., Ramadan, K., Villani, G., Spadari, S., Hubscher, U., and Maga, G. (2003) Biochemistry 42, 7467–7476[CrossRef][Medline] [Order article via Infotrieve]
  18. Maga, G., Shevelev, I., Villani, G., Spadari, S., and Hubscher, U. (2006) Nucleic Acids Res. 34, 1405–1415[Abstract/Free Full Text]
  19. Vaisman, A., Ling, H., Woodgate, R., and Yang, W. (2005) EMBO J. 24, 2957–2967[CrossRef][Medline] [Order article via Infotrieve]
  20. Tissier, A., McDonald, J. P., Frank, E. G., and Woodgate, R. (2000) Genes Dev. 14, 1642–1650[Abstract/Free Full Text]
  21. Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S., and Prakash, L. (2000) Nature 406, 1015–1019[CrossRef][Medline] [Order article via Infotrieve]
  22. Zhang, Y., Yuan, F., Wu, X., and Wang, Z. (2000) Mol. Cell. Biol. 20, 7099–7108[Abstract/Free Full Text]
  23. Bebenek, K., Tissier, A., Frank, E. G., McDonald, J. P., Prasad, R., Wilson, S. H., Woodgate, R., and Kunkel, T. A. (2001) Science 291, 2156–2159[Abstract/Free Full Text]
  24. Vaisman, A., Tissier, A., Frank, E. G., Goodman, M. F., and Woodgate, R. (2001) J. Biol. Chem. 276, 30615–30622[Abstract/Free Full Text]
  25. Masutani, C., Kusumoto, R., Yamada, A., Dohmae, N., Yokoi, M., Yuasa, M., Araki, M., Iwai, S., Takio, K., and Hanaoka, F. (1999) Nature 399, 700–704[CrossRef][Medline] [Order article via Infotrieve]
  26. Zhang, Y., Yuan, F., Wu, X., Wang, M., Rechkoblit, O., Taylor, J. S., Geacintov, N. E., and Wang, Z. (2000) Nucleic Acids Res. 28, 4138–4146[Abstract/Free Full Text]
  27. Creighton, S., Bloom, L. B., and Goodman, M. F. (1995) Methods Enzymol. 262, 232–256[Medline] [Order article via Infotrieve]
  28. Frank, E. G., Tissier, A., McDonald, J. P., Rapic-Otrin, V., Zeng, X., Gearhart, P. J., and Woodgate, R. (2001) EMBO J. 20, 2914–2922[CrossRef][Medline] [Order article via Infotrieve]
  29. Vidal, A. E., Kannouche, P., Podust, V. N., Yang, W., Lehmann, A. R., and Woodgate, R. (2004) J. Biol. Chem. 279, 48360–48368[Abstract/Free Full Text]
  30. Tissier, A., Frank, E. G., McDonald, J. P., Iwai, S., Hanaoka, F., and Woodgate, R. (2000) EMBO J. 19, 5259–5266[CrossRef][Medline] [Order article via Infotrieve]
  31. Vaisman, A., Frank, E. G., Iwai, S., Ohashi, E., Ohmori, H., Hanaoka, F., and Woodgate, R. (2003) DNA Repair 2, 991–1006[CrossRef][Medline] [Order article via Infotrieve]
  32. Johnson, R. E., Washington, M. T., Prakash, S., and Prakash, L. (2000) J. Biol. Chem. 275, 7447–7450[Abstract/Free Full Text]
  33. Masutani, C., Kusumoto, R., Iwai, S., and Hanaoka, F. (2000) EMBO J. 19, 3100–3109[CrossRef][Medline] [Order article via Infotrieve]
  34. McCulloch, S. D., Kokoska, R. J., Masutani, C., Iwai, S., Hanaoka, F., and Kunkel, T. A. (2004) Nature 428, 97–100[CrossRef][Medline] [Order article via Infotrieve]
  35. Frank, E. G., Sayer, J. M., Kroth, H., Ohashi, E., Ohmori, H., Jerina, D. M., and Woodgate, R. (2002) Nucleic Acids Res. 30, 5284–5292[Abstract/Free Full Text]
  36. Goldschmidt, V., Didierjean, J., Ehresmann, B., Ehresmann, C., Isel, C., and Marquet, R. (2006) Nucleic Acids Res. 34, 42–52[Abstract/Free Full Text]
  37. Gee, J. B., II, Corbett, R. J., Perlman, J. M., and Laptook, A. R. (2001) Pediatr. Neurol. 25, 304–308[CrossRef][Medline] [Order article via Infotrieve]
  38. Choi, J. Y., Chowdhury, G., Zang, H., Angel, K. C., Vu, C. C., Peterson, L. A., and Guengerich, F. P. (2006) J. Biol. Chem. 281, 38244–38256[Abstract/Free Full Text]
  39. Johnson, R. E., Haracska, L., Prakash, L., and Prakash, S. (2006) Mol. Cell. Biol. 26, 6435–6441[Abstract/Free Full Text]
  40. Nair, D. T., Johnson, R. E., Prakash, L., Prakash, S., and Aggarwal, A. K. (2006) Nat. Struct. Mol. Biol. 13, 619–625[CrossRef][Medline] [Order article via Infotrieve]
  41. Choi, J. Y., and Guengerich, F. P. (2006) J. Biol. Chem. 281, 12315–12324[Abstract/Free Full Text]
  42. Johnson, R. E., Prakash, L., and Prakash, S. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 10466–10471[Abstract/Free Full Text]
  43. Ash, D. E., and Schramm, V. L. (1982) J. Biol. Chem. 257, 9261–9264[Free Full Text]
  44. Markesbery, W. R., Ehmann, W. D., Alauddin, M., and Hossain, T. I. (1984) Neurobiol. Aging 5, 19–28[CrossRef][Medline] [Order article via Infotrieve]
  45. Versieck, J. (1985) Crit. Rev. Clin. Lab. Sci. 22, 97–184[Medline] [Order article via Infotrieve]
  46. Dumstorf, C. A., Clark, A. B., Lin, Q., Kissling, G. E., Yuan, T., Kucherlapati, R., McGregor, W. G., and Kunkel, T. A. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 18083–18088[Abstract/Free Full Text]
  47. Ohkumo, T., Kondo, Y., Yokoi, M., Tsukamoto, T., Yamada, A., Sugimoto, T., Kanao, R., Higashi, Y., Kondoh, H., Tatematsu, M., Masutani, C., and Hanaoka, F. (2006) Mol. Cell. Biol. 26, 7696–7706[Abstract/Free Full Text]
  48. Wang, Y., Woodgate, R., McManus, T. P., Mead, S., McCormick, J. J., and Maher, V. M. (2007) Cancer Res. 67, 3018–3026[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
L. S. Waters, B. K. Minesinger, M. E. Wiltrout, S. D'Souza, R. V. Woodruff, and G. C. Walker
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Microbiol. Mol. Biol. Rev., March 1, 2009; 73(1): 134 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Pence, P. Blans, C. N. Zink, T. Hollis, J. C. Fishbein, and F. W. Perrino
Lesion Bypass of N2-Ethylguanine by Human DNA Polymerase {iota}
J. Biol. Chem., January 16, 2009; 284(3): 1732 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. S. Plosky, E. G. Frank, D. A. Berry, G. P. Vennall, J. P. McDonald, and R. Woodgate
Eukaryotic Y-family polymerases bypass a 3-methyl-2'-deoxyadenosine analog in vitro and methyl methanesulfonate-induced DNA damage in vivo
Nucleic Acids Res., April 1, 2008; 36(7): 2152 - 2162.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/34/24689    most recent
M702159200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, E. G.
Right arrow Articles by Woodgate, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, E. G.
Right arrow Articles by Woodgate, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement